Background Candesartan cilexetil (CC) is a selective angiotensin II receptor antagonist widely used to treat hypertension. CC is a substrate of P-glycoprotein (P-gp), causing its …
PK Karnakova, TN Komarov… - Drug development & …, 2021 - pharmjournal.ru
Introduction. Combined drugs have the greatest efficacy and safety in arterial hypertension treatment. The combination of candesartan and hydrochlorothiazide (AT 1-receptor …
H Khan - Asian Journal of Pharmaceutical Analysis, 2020 - indianjournals.com
In the presented work the Ultra-high performance Liquid Chromatographic-Photodiode Array Detection (UHPLC-PDA) method has been developed and validated for Simultaneous …
НП Сачивкина, АН Сенягин… - Разработка и …, 2021 - pharmjournal.ru
Аннотация Введение. Клинические штаммы микроорганизмов, в том числе и условно- патогенные дрожжеподобные грибы (ДПГ) рода Candida, обладают устойчивостью к …
Objectives: This work aimed to develop a simple HPLC method and apply in the pharmaceutical equivalence study of seven imported and one local product of candesartan …
K Hephzibah, S Shanmugasundaram - International journal of health sciences - neliti.com
Objective: The focus of this study was to establish a simple, robust, and validated RP-column approach to analyze Candesartan and Pioglitazone in a bilayer tablet dosage form. To …